Eugia Pharma gets USFDA nod for posaconazole injection, 300 mg/16.7 mL, single-dose vial EP News Bureau Dec 27, 2023 The approved product has an estimated market size of $25.4 million for the twelve months ending October 2023, according to IQVIA
Lupin launches Posaconazole Delayed-Release Tablets EP News Bureau Feb 17, 2021 They are indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing…
